MUTYH as an Emerging Predictive Biomarker in Ovarian Cancer

Approximately 18% of ovarian cancers have an underlying genetic predisposition and many of the genetic alterations have become intervention and therapy targets. Although mutations in MutY homolog (MUTYH) are best known for MUTYH associated polyposis and colorectal cancer, it plays a role in the deve...

Descripción completa

Detalles Bibliográficos
Autores principales: Hutchcraft, Megan L., Gallion, Holly H., Kolesar, Jill M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825630/
https://www.ncbi.nlm.nih.gov/pubmed/33419231
http://dx.doi.org/10.3390/diagnostics11010084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825630/
https://www.ncbi.nlm.nih.gov/pubmed/33419231
http://dx.doi.org/10.3390/diagnostics11010084

Ejemplares similares